A Systematic Review of the Tumor-Infiltrating CD8(+) T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology

Based on preclinical findings, programmed death-ligand 1 (PD-L1) can substantially attenuate CD8(+) T-cell-mediated anti-tumoral immune responses. However, clinical studies have reported controversial results regarding the significance of the tumor-infiltrating CD8(+) T-cells/PD-L1 axis on the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Shadbad, Mahdi Abdoli, Asadzadeh, Zahra, Hosseinkhani, Negar, Derakhshani, Afshin, Alizadeh, Nazila, Brunetti, Oronzo, Silvestris, Nicola, Baradaran, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486082/
https://www.ncbi.nlm.nih.gov/pubmed/34603316
http://dx.doi.org/10.3389/fimmu.2021.734956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486082/
https://www.ncbi.nlm.nih.gov/pubmed/34603316
http://dx.doi.org/10.3389/fimmu.2021.734956

Ejemplares similares